| ishares Edge MSCI Australia Minimum Volatility ETF (MVOL) |
Financials |
$29 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$35.430 |
$35.150 |
fallen by
0.79%
|
|
| iShares S&P 500 ETF (IVV) |
Financials |
$12,440 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$63.180 |
$64.230 |
risen by
1.66%
|
|
| iShares MSCI EAFE ETF (IVE) |
Financials |
$668 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$138.320 |
$145.550 |
risen by
5.23%
|
|
| iShares Global High Yield Bond (AUD Hedged) ETF (IHHY) |
Financials |
$370 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$94.510 |
$95.670 |
risen by
1.23%
|
|
| iShares Asia 50 ETF (IAA) |
Financials |
$1,361 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$125.950 |
$160.200 |
risen by
27.19%
|
|
| iShares Global Healthcare ETF (IXJ) |
Financials |
$1,406 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$131.070 |
$140.000 |
risen by
6.81%
|
|
| iShares Core S&P/ASX 200 ETF (IOZ) |
Financials |
$8,048 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$34.590 |
$35.750 |
risen by
3.35%
|
|
| Ishares Enhanced Cash ETF (ISEC) |
Financials |
$520 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$100.960 |
$100.570 |
fallen by
0.39%
|
|
| iShares Core Global Corporate Bond (AUD Hedged) ETF (IHCB) |
Financials |
$327 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$92.460 |
$93.750 |
risen by
1.40%
|
|
| iShares Edge MSCI World Minimum Volatility ETF (WVOL) |
Financials |
$78 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$44.090 |
$44.460 |
risen by
0.84%
|
|
| iShares S&P Mid-Cap ETF (IJH) |
Financials |
$471 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$47.730 |
$49.770 |
risen by
4.27%
|
|
| Ishares Government Inflation ETF (ILB) |
Financials |
$1,070 |
FINAL DISTRIBUTION ANNOUNCEMENT
|
1 Jul 2025 8:32AM |
$126.070 |
$126.200 |
risen by
0.10%
|
|
| Metro Mining Limited (MMI) ORDINARY FULLY PAID |
Materials |
$397 |
Change of Director's Interest Notice
|
1 Jul 2025 8:32AM |
$0.065 |
$0.065 |
fallen by
0%
|
|
| Norwood Systems Limited (NOR) ORDINARY FULLY PAID |
Information Technology |
$8 |
Norwood varies cash drawdown facility
|
1 Jul 2025 8:32AM |
$0.020 |
$0.015 |
fallen by
25%
|
|
NOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Norwood Systems Limited has entered into a varied cash drawdown facility agreement with Radium Capital.
- The facility provides access to up to 85% of anticipated R&D tax incentive refunds.
- The total facility limit is $1,000,000 with a minimum drawdown of $50,000 per request.
- The facility replaces the previous arrangement and is available until 31 May 2025 or until the R&D tax incentive refund is received.
- The agreement includes specified interest and fees, and is secured against R&D tax incentive entitlements.
- Funds drawn will be used to support Norwood’s operations and innovation activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metro Mining Limited (MMI) ORDINARY FULLY PAID |
Materials |
$397 |
Change of Director's Interest Notice
|
1 Jul 2025 8:32AM |
$0.065 |
$0.065 |
fallen by
0%
|
|
| Maronan Metals Limited (MMA) ORDINARY FULLY PAID |
Materials |
$121 |
Notification of cessation of securities - MMA
|
1 Jul 2025 8:32AM |
$0.210 |
$0.480 |
risen by
128.57%
|
|
| ImpediMed Limited (IPD) ORDINARY FULLY PAID |
Health Care |
$37 |
Change of registered and business address
|
1 Jul 2025 8:32AM |
$0.035 |
$0.018 |
fallen by
48.57%
|
|
| Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$687 |
Presentation - July Investor Update
|
1 Jul 2025 8:32AM |
$0.290 |
$0.495 |
risen by
70.69%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,966 |
Update - Notification of buy-back - APE
|
1 Jul 2025 8:32AM |
$17.450 |
$24.670 |
risen by
41.38%
|
|
| NH3 Clean Energy Limited (NH3) ORDINARY FULLY PAID |
Materials |
$53 |
NH3 McIntosh Graphite Project Partner GCM Releases PFS
|
1 Jul 2025 8:32AM |
$0.032 |
$0.075 |
risen by
134.38%
|
|
NH3 - Price-sensitive ASX Announcement
Full Release
Key Points
- NH3 Clean Energy Limited and partner GCM have published the Pre-Feasibility Study (PFS) for the McIntosh Graphite Project.
- The PFS demonstrates strong project economics, including favorable NPV and IRR figures.
- McIntosh Graphite Project will produce high-quality flake graphite for energy storage and clean energy markets.
- Significant graphite resources and potential for further resource growth are highlighted.
- The project is strategically positioned to support clean energy and battery manufacturing supply chains.
- Environmental sustainability and low-carbon operations are emphasized as key project features.
- Detailed production, capital, and operational expenditure estimates are provided in the study.
- Potential for value-add processing and vertical integration within NH3 Clean Energy's business strategy is discussed.
- The PFS results reinforce the attractiveness of the McIntosh Project as a long-term, sustainable graphite source.
- NH3 Clean Energy remains committed to project advancement and stakeholder engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| King River Resources Limited (KRR) ORDINARY FULLY PAID |
Materials |
$32 |
Notification of cessation of securities - KRR
|
1 Jul 2025 8:31AM |
$0.008 |
$0.022 |
risen by
175%
|
|
| Santana Minerals Limited (SMI) ORDINARY FULLY PAID |
Materials |
$824 |
Presentation - Updated Pre-Feasibility Study
|
1 Jul 2025 8:31AM |
$0.520 |
$0.985 |
risen by
89.42%
|
|
SMI - Price-sensitive ASX Announcement
Full Release
Key Points
- SMI updated Pre-Feasibility Study for the Rise and Shine (RAS) Gold Project in New Zealand.
- Significant increase in JORC Resources to 78Mt @ 1.1 g/t Au for 2.8Moz, and Ore Reserves to 46Mt @ 1.2 g/t Au for 1.8Moz.
- Mine life extended to 12 years with annual production of approximately 120koz of gold in initial years.
- Low forecast All-In Sustaining Cost (AISC) of NZ$1,112/oz over life of mine.
- Post-tax NPV5% of NZ$1,301 million and IRR of 52% at NZ$3,150/oz gold price.
- Open-pit mining and conventional CIP gold processing plant proposed.
- Strong ESG focus with plans for progressive rehabilitation, community engagement, and low carbon footprint.
- Positive engagement with local iwi, landowners, and stakeholders regarding permitting and development.
- Scope for further resource expansion and production upside through exploration of additional targets.
- Significant economic and social benefits for the Central Otago region anticipated from project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Future Battery Minerals Limited (FBM) ORDINARY FULLY PAID |
Materials |
- |
Historical Shallow Drill Results at Burbanks East
|
1 Jul 2025 8:31AM |
$0.019 |
$0.065 |
risen by
242.11%
|
|
FBM - Price-sensitive ASX Announcement
Full Release
Key Points
- FBM reviewed historical shallow drilling data at Burbanks East.
- Significant lithium mineralisation identified in old drill holes.
- Some historical samples were not previously assayed for lithium.
- Re-assaying of pulps revealed new lithium pegmatite zones.
- Additional exploration including drilling and sampling is planned.
- The results highlight the lithium prospectivity of the Burbanks East Project.
- FBM aims to expand its lithium project portfolio in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$130 |
Paradigm Secures US$27M to Advance Phase 3 OA Trial
|
1 Jul 2025 8:31AM |
$0.305 |
$0.300 |
fallen by
1.64%
|
|
PAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Paradigm Biopharmaceuticals secured US$27 million to fund its Phase 3 OA trial.
- The capital will be utilized to progress clinical development and approach potential commercialization of pentosan polysulfate sodium (PPS).
- Funding sources and detailed allocation of proceeds are described.
- The Phase 3 trial for OA pain management remains a central focus, with updates on recruitment and trial milestones.
- The announcement covers operational updates, partnership details, and market opportunity linked to OA treatment.
- Paradigm emphasizes the ongoing unmet need in OA and the potential impact of its investigational drug.
- Timelines for Phase 3 trial progression and upcoming regulatory milestones are presented.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$315 |
Update - Notification of buy-back - SVR
|
1 Jul 2025 8:31AM |
$1.675 |
$1.670 |
fallen by
0.30%
|
|